PBX3 is an important cofactor of HOXA9 in leukemogenesis

Author:

Li Zejuan1,Zhang Zhiyu2,Li Yuanyuan1,Arnovitz Stephen1,Chen Ping1,Huang Hao1,Jiang Xi1,Hong Gia-Ming1,Kunjamma Rejani B.1,Ren Haomin1,He Chunjiang1,Wang Chong-Zhi2,Elkahloun Abdel G.3,Valk Peter J. M.4,Döhner Konstanze5,Neilly Mary Beth1,Bullinger Lars5,Delwel Ruud4,Löwenberg Bob4,Liu Paul P.3,Morgan Richard6,Rowley Janet D.1,Yuan Chun-Su2,Chen Jianjun1

Affiliation:

1. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL;

2. Tang Center for Herbal Medicine Research, University of Chicago, Chicago, IL;

3. Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD;

4. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;

5. Department of Internal Medicine III, University of Ulm, Ulm, Germany; and

6. Postgraduate Medical School, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom

Abstract

Key Points PBX3 is a critical co-factor of HOXA9 in AMLs, particularly those carrying MLL rearrangements. Targeting HOXA9/PBX3 interaction holds a therapeutic potential to treat leukemia.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3